Single-Cell Sequencing Uncovers a TMSB10-Expressing Fibroblast Subpopulation Driving Renal Fibrosis in Diabetic Nephropathy
This study identifies TMSB10 as a novel fibroblast-specific regulator of renal fibrosis in DN, acting through the TGF-β/SMAD pathway. These findings expand current understanding of fibroblast heterogeneity and highlight TMSB10 as a potential therapeutic target for DN and other fibrotic diseases. Limitations include validation in a limited sample size and the use of murine fibroblast models, warranting further confirmation in human primary cells.
Authors
- Liexiang Zhang (ORCID: https://orcid.org/0009-0004-2571-025X)
- Zihan Qin
- Xiaohong Xu (ORCID: https://orcid.org/0000-0002-3860-9845)
- Ke Du
- Yuepeng Fang
- Xiaoli Huang
Institutions
- Jiangsu University (CN)
- Shandong University (CN)
- Nantong University (CN)
- Affiliated Hospital of Nantong University (CN)
- Jinan Central Hospital (CN)
- Affiliated Hospital of Jiangsu University (CN)
- Second People's Hospital of NanTong (CN)
- Shandong Provincial Hospital (CN)
- Nanjing Medical University (CN)
Publication Details
- Journal
- Diabetes Metabolic Syndrome and Obesity
- Published
- 2025-12-01
- DOI
- https://doi.org/10.2147/dmso.s559695
- Primary Topic
- Chronic Kidney Disease and Diabetes
- Type
- article
- Field-Weighted Citation Impact
- 0.00